Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Parkinson Disease; Parkinsonian Disorders | Phase 2 | ClinicalTrials |
| Diabetes Mellitus; Diabetes Mellitus, Type 2 | Phase 1 | ClinicalTrials |
| Parkinsonian Disorders | Phase 2 | ClinicalTrials |
| Parkinson Disease | Phase 2 | ClinicalTrials |
| Alzheimer Disease; Dementia; Lewy Body Disease; Parkinson Disease | Phase 1/Phase 2 | ClinicalTrials |
| Diabetes Mellitus; Diabetes Mellitus, Type 2 | Phase 1 | ClinicalTrials |
| Movement Disorders; Parkinson Disease; Parkinsonian Disorders | Phase 2/Phase 3 | ClinicalTrials |
| Nerve Degeneration; Parkinson Disease; Parkinsonian Disorders | Phase 2 | ClinicalTrials |
CONTENTS